Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 1136 | 1.32 |
09:34 ET | 100 | 1.335 |
09:36 ET | 2202 | 1.32 |
09:38 ET | 200 | 1.315 |
09:39 ET | 100 | 1.31 |
09:41 ET | 100 | 1.315 |
09:45 ET | 200 | 1.315 |
09:48 ET | 600 | 1.315 |
09:50 ET | 3486 | 1.3201 |
09:52 ET | 100 | 1.325 |
09:54 ET | 8811 | 1.325 |
09:56 ET | 552 | 1.32 |
09:57 ET | 3590 | 1.325 |
10:01 ET | 550 | 1.33 |
10:03 ET | 1412 | 1.325 |
10:06 ET | 3516 | 1.33 |
10:08 ET | 300 | 1.3295 |
10:10 ET | 400 | 1.325 |
10:12 ET | 9050 | 1.345 |
10:14 ET | 15220 | 1.35 |
10:15 ET | 3374 | 1.345 |
10:19 ET | 5399 | 1.35 |
10:21 ET | 9753 | 1.36 |
10:24 ET | 11571 | 1.36 |
10:26 ET | 2900 | 1.36 |
10:28 ET | 5572 | 1.355 |
10:30 ET | 8271 | 1.36 |
10:32 ET | 11713 | 1.36 |
10:33 ET | 4300 | 1.36 |
10:35 ET | 1962 | 1.36 |
10:37 ET | 200 | 1.3549 |
10:39 ET | 100 | 1.355 |
10:44 ET | 13673 | 1.33 |
10:46 ET | 500 | 1.33 |
10:48 ET | 300 | 1.335 |
10:50 ET | 300 | 1.33 |
10:51 ET | 10907 | 1.325 |
10:53 ET | 766 | 1.325 |
10:55 ET | 3399 | 1.325 |
10:57 ET | 5187 | 1.33 |
11:00 ET | 4242 | 1.32 |
11:02 ET | 3100 | 1.325 |
11:04 ET | 1577 | 1.3295 |
11:06 ET | 100 | 1.325 |
11:08 ET | 1400 | 1.325 |
11:09 ET | 2187 | 1.33 |
11:11 ET | 2937 | 1.325 |
11:13 ET | 2387 | 1.325 |
11:15 ET | 4538 | 1.33 |
11:18 ET | 2550 | 1.34 |
11:20 ET | 3384 | 1.34 |
11:22 ET | 2000 | 1.3301 |
11:24 ET | 799 | 1.331 |
11:26 ET | 3286 | 1.3301 |
11:27 ET | 100 | 1.33 |
11:29 ET | 5237 | 1.32 |
11:31 ET | 800 | 1.325 |
11:33 ET | 7084 | 1.31 |
11:36 ET | 600 | 1.32 |
11:38 ET | 300 | 1.315 |
11:40 ET | 605 | 1.315 |
11:42 ET | 300 | 1.31 |
11:44 ET | 600 | 1.315 |
11:45 ET | 4213 | 1.315 |
11:47 ET | 9274 | 1.31 |
11:49 ET | 657 | 1.305 |
11:51 ET | 1086 | 1.305 |
11:54 ET | 1150 | 1.305 |
11:56 ET | 800 | 1.305 |
11:58 ET | 6756 | 1.31 |
12:00 ET | 900 | 1.31 |
12:02 ET | 400 | 1.31 |
12:03 ET | 1478 | 1.31 |
12:05 ET | 754 | 1.31 |
12:07 ET | 600 | 1.31 |
12:09 ET | 900 | 1.315 |
12:12 ET | 300 | 1.31 |
12:14 ET | 300 | 1.31 |
12:16 ET | 1578 | 1.3132 |
12:18 ET | 500 | 1.31 |
12:20 ET | 300 | 1.305 |
12:21 ET | 700 | 1.305 |
12:23 ET | 800 | 1.3019 |
12:25 ET | 500 | 1.305 |
12:27 ET | 200 | 1.305 |
12:30 ET | 492 | 1.305 |
12:32 ET | 1000 | 1.3 |
12:34 ET | 15160 | 1.3 |
12:36 ET | 1800 | 1.3 |
12:38 ET | 595 | 1.305 |
12:39 ET | 700 | 1.3 |
12:41 ET | 1080 | 1.3 |
12:43 ET | 400 | 1.3 |
12:45 ET | 9500 | 1.3 |
12:48 ET | 3977 | 1.3 |
12:50 ET | 4800 | 1.3 |
12:52 ET | 9955 | 1.3 |
12:54 ET | 1695 | 1.3 |
12:56 ET | 9011 | 1.3 |
12:57 ET | 3696 | 1.3 |
12:59 ET | 18921 | 1.3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 101.3M | 6.6x | --- |
Spero Therapeutics Inc | 71.5M | 3.1x | --- |
2Seventy Bio Inc | 206.1M | -0.9x | --- |
Rigel Pharmaceuticals Inc | 135.7M | -6.8x | --- |
G1 Therapeutics Inc | 134.4M | -4.2x | --- |
Seres Therapeutics Inc | 106.3M | -1.2x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $101.3M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 6.6x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | 5.5x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.